 |
|
|
| |
48-Week Safety and Efficacy On-Treatment Analysis of
Ibalizumab in Patients with Multi-Drug Resistant HIV-1
|
| |
| |
Brinda Emu, MD
Yale University
Presentation
Friday, October 6
IDWeek 2017
Reported by Jules Levin
Reported by Jules Levin
IDWeek2017/IDSA, October 4-8, 2017, San Diego
|
| |
|
|
|
|
|
